Don Mudzengi
Overview
Explore the profile of Don Mudzengi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
93
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Balasubramanian R, Shearer K, Mudzengi D, Hippner P, Golub J, Chihota V, et al.
AIDS
. 2023 Aug;
37(15):2371-2379.
PMID: 37650763
Objectives: Targeted universal tuberculosis (TB) testing can improve TB detection among people with HIV. This approach is being scaled up in South Africa through Xpert MTB/RIF Ultra testing for individuals...
2.
Sweeney S, Capeding T, Eggo R, Huda M, Jit M, Mudzengi D, et al.
BMJ Glob Health
. 2021 May;
6(5).
PMID: 34039588
Background: Policy makers need to be rapidly informed about the potential equity consequences of different COVID-19 strategies, alongside their broader health and economic impacts. While there are complex models to...
3.
Bozzani F, Sumner T, Mudzengi D, Gomez G, White R, Vassall A
Value Health
. 2020 Oct;
23(11):1462-1469.
PMID: 33127017
Objectives: Health systems face nonfinancial constraints that can influence the opportunity cost of interventions. Empirical methods to explore their impact, however, are underdeveloped. We develop a conceptual framework for defining...
4.
Sweeney S, Vassall A, Guinness L, Siapka M, Chimbindi N, Mudzengi D, et al.
Pharmacoeconomics
. 2020 Apr;
38(6):619-631.
PMID: 32239479
Background And Objective: In context of the End TB goal of zero tuberculosis (TB)-affected households encountering catastrophic costs due to TB by 2020, the estimation of national prevalence of catastrophic...
5.
Sumner T, Bozzani F, Mudzengi D, Hippner P, Houben R, Cardenas V, et al.
Am J Epidemiol
. 2019 Mar;
188(6):1155-1164.
PMID: 30824911
Mathematical models are increasingly being used to compare strategies for tuberculosis (TB) control and inform policy decisions. Models often do not consider financial and other constraints on implementation and may...
6.
Hippner P, Sumner T, Houben R, Cardenas V, Vassall A, Bozzani F, et al.
PLoS One
. 2019 Jan;
14(1):e0209320.
PMID: 30682028
South Africa has the highest tuberculosis (TB) disease incidence rate in the world, and TB is the leading infectious cause of death. Decisions on, and funding for, TB prevention and...
7.
Bozzani F, Mudzengi D, Sumner T, Gomez G, Hippner P, Cardenas V, et al.
Cost Eff Resour Alloc
. 2018 Aug;
16:27.
PMID: 30069166
Background: Evidence on the relative costs and effects of interventions that do not consider 'real-world' constraints on implementation may be misleading. However, in many low- and middle-income countries, time and...
8.
Mudzengi D, Sweeney S, Hippner P, Kufa T, Fielding K, Grant A, et al.
Health Policy Plan
. 2017 Feb;
32(suppl_4):iv48-iv56.
PMID: 28204500
Background: This study describes the post-diagnosis care-seeking costs incurred by people living with TB and/or HIV and their households, in order to identify the potential benefits of integrated care. Methods:...
9.
Sweeney S, Vassall A, Foster N, Simms V, Ilboudo P, Kimaro G, et al.
Health Econ
. 2016 Jan;
25 Suppl 1:42-52.
PMID: 26774106
Out-of-pocket spending is increasingly recognized as an important barrier to accessing health care, particularly in low-income and middle-income countries (LMICs) where a large portion of health expenditure comes from out-of-pocket...